15 June 2009

Editorial: Surgery or PCI for multivessel disease: Doctor’s choice is best
By: Christian Hamm
There is great debate about what treatment is best for multivessel coronary artery disease: PCI or CABG. The SYNTAX trial gave some new insights, but it also confirms what has been reasonable practice already. Christian Hamm reviews the topic.

28 April 2009

Editorial: What is an acute myocardial infarction?
By: Russell V. Luepker
The accurate diagnosis of acute myocardial infarction (AMI) is crucial for therapy, clinical trials and population research. But the diagnosis is in flux as new and more sensitive diagnostic measures become widely available and the presentation of AMI in hospital changes. Russell Luepker discusses these shifts and recent recommendations for the diagnosis of AMI by authoritative bodies.

20 January 2009

Editorial: EUROACTION: Using what we know to improve primary and secondary prevention of coronary heart disease
By: Martin O’Flaherty and Simon Capewell
The delivery of effective evidence-based treatments for primary and secondary prevention is now one of the key strategies in controlling coronary heart disease burden, but there is still no consensus on what is needed and what are the priorities. Martin O’Flaherty and Simon Capewell discuss the results of the EUROACTION trial, which provides insight on what could be achieved by targeting high-risk patients.